CSHL | GenomeWeb

CSHL

Meeting organizer Jennifer Doudna explained how CRISPR has become an everyday research tool and how next year's meeting will feature more diverse applications.

More than half the transcripts Cold Spring Harbor Laboratory researchers captured were novel, including novel isoforms of known genes.

In Genome Research this week: transcriptomic analysis of the Venus flytrap, SMASH approach for CNV analysis, and more.

Elaine Mardis of Washington University in St. Louis described genome-guided efforts to identify neoantigen targets for cancer vaccines in melanoma and other cancer types.

Double helix sculpture at CSHL

Researchers found that a parasitic amoeba influences its the composition and diversity of the gut microbiomes of rural Cameroonians.

Early results of a study suggest at least some recurrent gene mutations differ by breed for dogs affected by B-cell and/or T-cell lymphomas.

The École Polytechnique Fédérale de Lausanne's Samira Asgari uncovered rare variants that seem to govern an extreme response to RSV or HRV infection.

Researchers used genomic approaches to search for disease clues in purified cells from ileum or colon biopsies of pediatric inflammatory bowel disease patients.

Using UK10K project data, a Stanford University-led team described polygenic adaptations contributing to complex human traits over the past 2,000 years.

JHU's Alexis Battle is using whole-genome sequencing and RNA-sequencing data to identify and study the functional effects of rare non-coding variants.

Pages

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.